Analysis of the advances in pancreatic cancer research from 2017 annual meeting of Chinese Society of Clinical Oncology

Pancreatic cancer is a highly malignant, fast progressive digestive system neoplasm with poor prognosis, and the incidence has increased significantly in recent years. With deepening of the molecular mechanism of pancreatic cancer, researchers indeed have a clearer understanding of the disease, which provides clues for translation of basic research into clinical practice. The 2017 annual meeting of the Chinese Society of Clinical Oncology (CSCO) was held in Xiamen on September 26th to 30th. In this paper, authors selected and reviewed advances in pancreatic cancer research on surgical treatment, chemotherapy, radiotherapy, targeted therapy and immunotherapy on pancreatic cancer from 2017 CSCO, in order to provide new clues for optimization of diagnosis and treatment of pancreatic cancer.